The incidence of venous thromboembolism (VTE) in cancer patients may have changed in
the past decade, possibly due to novel cancer therapies, improved survival, and high …

Patients with severe infections and a pre-existing indication for antithrombotic therapy, ie
antiplatelet agents, anticoagulant drugs, or their combinations, require integrated clinical …

Cancer and coronavirus disease 2019 (COVID-19) have unusual similarities: they both
result in a markedly elevated risk of thrombosis, exceptionally high D-dimer levels, and the …

Objective Accumulating evidence suggests that cancer survivors may have a relatively
higher risk of stroke. The aim of this meta-analysis was to determine whether cancer …

Current recommended risk scores to predict thrombotic events associated with
myeloproliferative neoplasms (MPN) do not discriminate between arterial and venous …

Background The psychologic consequences of acute venous thromboembolism (VTE) have
not been investigated in depth. Objectives We aimed to examine the association between …

Purpose The aim of this study was to describe the incidence of venous thromboembolism
(VTE) and major bleeding among hospitalized patients with hematologic malignancy …

Patients with hematologic malignancies (HMs) are at risk of future cardiovascular (CV)
events. We therefore conducted a systematic review and meta-analysis to quantify their risk …

Introduction Although many publications have reported the incidence of venous
thromboembolism (VTE) in patients with cancer from Western countries, to date, no …

Background Venous thromboembolism (VTE) may complicate the clinical course of cancer
patients and add to their psychological burden. Objectives We aimed to investigate the …